Founder mutations in <it>BRCA1/2 </it>are not frequent in Canadian Ashkenazi Jewish men with prostate cancer

<p>Abstract</p> <p>Background</p> <p>Relatives of <it>BRCA1 </it>and <it>BRCA2 </it>mutation carriers have long been proposed by epidemiological studies to have an increased risk of developing prostate cancer. In the Ashkenazi Jewish (AJ) populat...

Full description

Bibliographic Details
Main Authors: Kotar Kimberley, Hamel Nancy, Foulkes William D
Format: Article
Language:English
Published: BMC 2003-08-01
Series:BMC Medical Genetics
Subjects:
Online Access:http://www.biomedcentral.com/1471-2350/4/7